Vantia is an emerging pharmaceutical company developing novel small molecule drugs targeting large areas of unmet medical need.
Following its spin-out from Ferring, EJPC provided launch and initial financial communications.
Vantia is an emerging pharmaceutical company developing novel small molecule drugs targeting large areas of unmet medical need.